Capital Insight Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.49M Sell
50,605
-4,702
-9% -$325K 0.61% 54
2025
Q1
$3.84M Buy
55,307
+3,095
+6% +$215K 0.67% 49
2024
Q4
$4.49M Buy
52,212
+6,008
+13% +$517K 0.78% 46
2024
Q3
$5.5M Buy
46,204
+1,929
+4% +$230K 0.96% 33
2024
Q2
$6.32M Sell
44,275
-1,129
-2% -$161K 1.19% 24
2024
Q1
$5.83M Buy
45,404
+674
+2% +$86.5K 1.09% 25
2023
Q4
$4.63M Buy
44,730
+518
+1% +$53.6K 0.95% 31
2023
Q3
$4.02M Buy
44,212
+2,038
+5% +$185K 0.91% 34
2023
Q2
$3.41M Sell
42,174
-412
-1% -$33.3K 0.76% 43
2023
Q1
$3.39M Buy
42,586
+1,096
+3% +$87.2K 0.8% 41
2022
Q4
$2.81M Buy
41,490
+342
+0.8% +$23.1K 0.73% 44
2022
Q3
$2.05M Buy
41,148
+1,722
+4% +$85.8K 0.55% 63
2022
Q2
$2.2M Sell
39,426
-166
-0.4% -$9.25K 0.51% 64
2022
Q1
$2.2M Sell
39,592
-1,598
-4% -$88.7K 0.45% 77
2021
Q4
$2.31M Buy
41,190
+2,048
+5% +$115K 0.47% 75
2021
Q3
$1.88M Buy
39,142
+1,290
+3% +$61.9K 0.41% 93
2021
Q2
$1.59M Buy
37,852
+1,710
+5% +$71.6K 0.36% 95
2021
Q1
$1.22M Buy
36,142
+890
+3% +$30K 0.3% 108
2020
Q4
$1.23M Buy
35,252
+426
+1% +$14.9K 0.31% 104
2020
Q3
$1.21M Sell
34,826
-598
-2% -$20.8K 0.34% 102
2020
Q2
$1.16M Sell
35,424
-156
-0.4% -$5.11K 0.37% 93
2020
Q1
$1.07M Buy
35,580
+1,790
+5% +$53.9K 0.57% 61
2019
Q4
$978K Sell
33,790
-52
-0.2% -$1.51K 0.45% 68
2019
Q3
$875K Sell
33,842
-256
-0.8% -$6.62K 0.76% 58
2019
Q2
$870K Buy
34,098
+570
+2% +$14.5K 0.76% 60
2019
Q1
$877K Buy
33,528
+304
+0.9% +$7.95K 0.79% 56
2018
Q4
$765K Buy
+33,224
New +$765K 0.79% 50